$130,51
▲ +$0,29
(+0,22%)
Vol. 75K
Cap. mercato
$5.7B
ROE
-23,7%
Margine
-30,6%
Beta
0,86
Rendimento div.
1,04%
52W
$100–$139
Consenso Wall Street
17 analisti · Apr 20261
Acquisto forte
4
Compra
11
Mantieni
1
Vendi
0
Vendita forte
29,4%
Rating Compra
Grafico dei Prezzi
Titoli simili
PEN
Penumbra Inc
P/E 73,4
$13.0B
GMED
Globus Medical Inc
P/E 23,7
$12.8B
BAX
Baxter International Inc
$9.3B
MASI
Masimo Corp
$7.0B
GKOS
Glaukos Corp
$7.1B
NVST
Envista Holdings Corp
P/E 93,9
$4.4B
IRTC
iRhythm Holdings, Inc
$5.7B
TMDX
Transmedics Group Inc
P/E 45,3
$4.2B
ITGR
Integer Holdings Corp
P/E 29,6
$3.0B
ABT
Abbott Laboratories
P/E 26,3
$165.2B
Utili
Tasso di battuta: 50,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $3,77 | $1,93 | $-1,84 |
| Set 2025 | $3,42 | $3,67 | +$0,25 |
| Giu 2025 | $3,40 | $3,73 | +$0,33 |
| Mar 2025 | $2,95 | $2,91 | $-0,04 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $795.4M | $700.7M | $780.9M | $913.0M | -$401.9M |
| Utile netto | — | -$136.7M | $95.0M | $122.6M | -$408.9M | -$714.3M |
Trend fondamentali
| Metrica | 2026-04-12 | 2026-04-17 |
|---|---|---|
| ROE (TTM) | -23.7% | -23.7% |
| P/E (TTM) | — | — |
| Net Margin | -30.6% | -30.6% |
| Gross Margin | 53.3% | 53.3% |
| D/E Ratio | — | — |
| Current Ratio | 2.54 | 2.54 |
Rapporti chiave
ROA (TTM)
-12,3%
P/S (TTM)
1,93
P/B
1,7
EPS (TTM)
$-20,56
CF/Share
$13,58
Crescita ricavi 3A
-10,6%
52W High
$138,93
52W Low
$100,18
$100,18
Intervallo 52 settimane
$138,93
Salute finanziaria
Flusso di cassa libero
$151.6M
Debito netto
$2.3B
Liquidità
$378.6M
Debito totale
$2.7B
Aggiornato al Dic 31, 2025
Як TFX виглядає на тлі конкурентів у Health Care?
Група порівняння: Peers · Health Care (Peers) · 10 компаній
Оцінка TFX vs аналоги Health Care
P/E
—
▼
0%
sotto
peer
(34,5)
vs Peer
vs Settore
Valore equo
P/S
1,8
▼
56%
sotto
peer
(4,0)
vs Peer
vs Settore
Più costoso
P/B
1,7
▼
67%
sotto
peer
(5,2)
vs Peer
vs Settore
Più costoso
Дивідендна дохідність
1,1%
▲
7%
sopra
peer
(1,1%)
vs Peer
vs Settore
Rendimento basso
Прибутковість TFX vs аналоги Health Care
ROE
-23,7%
▼
287%
sotto
peer
(-6,1%)
vs Peer
vs Settore
Debole
Net margin
-30,6%
▼
995%
sotto
peer
(-2,8%)
vs Peer
vs Settore
Debole
Валова маржа
53,3%
▼
5%
sotto
peer
(55,9%)
vs Peer
vs Settore
Debole
ROA
-12,3%
▼
556%
sotto
peer
(-1,9%)
vs Peer
vs Settore
Debole
Фінансове здоровʼя TFX vs аналоги Health Care
D/E ratio
—
▼
0%
sotto
peer
(106,5)
vs Peer
vs Settore
In linea
Поточна ліквідність
2,5
▼
17%
sotto
peer
(3,1)
vs Peer
vs Settore
Liquidità bassa
Beta
0,8
▲
2%
sopra
peer
(0,8)
vs Peer
vs Settore
Meno volatile
Радар фундаменталів TFX
TFX
Mediana peer
Industria
TFX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
TFX vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
8
Vendite
0
DEREN JOHN
Chief Financial Officer · Mar 03
award
13784 shs
WINTERS JAMES
Officer · Mar 03
award
13007 shs
LOGUE DANIEL V.
General Counsel · Mar 03
award
9853 shs
HICKS CAMERON P
Officer · Mar 03
award
8096 shs
DEREN JOHN
Chief Financial Officer · Feb 23
award
161 shs
WINTERS JAMES
Officer · Feb 23
award
354 shs
LOGUE DANIEL V.
General Counsel · Feb 23
award
443 shs
HICKS CAMERON P
Officer · Feb 23
award
352 shs
Ultimo 90 giorni
Rendimenti acquisti insider
HAGGERTY GRETCHEN R
Ago 06, 2025
$57375
+13,75%
RYU JAEWON
Ago 05, 2025
$172500
+13,49%
KELLY LIAM J
Ago 05, 2025
$172605
+13,42%
RANDLE STUART A
Ago 05, 2025
$115860
+12,64%
KRAKAUER ANDREW A
Ago 05, 2025
$115250
+13,24%
Principali azionisti
Top 5: 47,97%Blackrock Inc.
12,08%
$632.1M
Vanguard Group Inc
10,77%
$563.4M
T. Rowe Price Investment Ma…
9,86%
$515.8M
Janus Henderson Group PLC
9,61%
$502.7M
Morgan Stanley
5,65%
$295.9M
Aggiornato al Dic 31, 2025
Dividendi
$1,36
/ anno
Mar 06, 2026
$0,3400
Nov 14, 2025
$0,3400
Ago 15, 2025
$0,3400
Mag 20, 2025
$0,3400
Mar 07, 2025
$0,3400
Nov 15, 2024
$0,3400
Ago 15, 2024
$0,3400
Mag 14, 2024
$0,3400